A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer

Background: Neoadjuvant chemotherapy with concurrent docetaxel, doxorubicin and cyclophosphamide is commonly used for patients with locally advanced breast cancer. Epirubicin is another anthracycline used in breast cancer but the concurrent use of epirubicin and taxane is not well-established. We co...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Xin, Hosenpud, Janet, Chitambar, Christopher R., Charlson, John, Cheng, Yee Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319980/
https://www.ncbi.nlm.nih.gov/pubmed/22481980
http://dx.doi.org/10.7150/jca.3980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319980/
https://www.ncbi.nlm.nih.gov/pubmed/22481980
http://dx.doi.org/10.7150/jca.3980

Ejemplares similares